observational cohort

Related by string. * Observational : observational cohort study . retrospective observational study . observational study . observational studies . observational humor / co horts . co hort . Cohorts . Cohort . cohorts : Swedish Mammography Cohort . longitudinal cohort study . dosing cohorts . retrospective cohort study . retrospective cohort * prospective observational cohort *

Related by context. Frequent words. (Click for all words.) 64 nonrandomized 64 Randomized controlled 62 prospective cohort 62 liver transplant recipients 62 prospectively defined 61 prospective observational 61 retrospective cohort study 60 patients undergoing percutaneous 60 HIV uninfected 60 thromboprophylaxis 59 placebo controlled clinical 59 pulmonary embolism PE 59 MERLIN TIMI 59 coronary revascularization 59 poor metabolizers 59 multicentre 59 substudy 58 Chronic Heart Failure 58 NHANES III 58 RRMS patients 58 Prostate Cancer Prevention 58 multicenter randomized 58 subgroup analyzes 58 prospective multicenter 58 carotid artery stenting 58 lipid lowering drugs 58 randomized multicenter 58 HSCT 58 atherothrombosis 57 placebo controlled randomized 57 kidney transplant recipients 57 blinded placebo controlled 57 Thrombolysis 57 Atherosclerosis Risk 57 recurrent miscarriage 57 subclinical hypothyroidism 57 double blinded placebo 57 placebo controlled studies 57 μg L 56 CALGB 56 lanthanum carbonate 56 prospective randomized controlled 56 paclitaxel eluting stents 56 phase Ib 56 placebo controlled trials 56 RCTs 56 logistic regression analysis 56 venous thromboembolic events 56 heavily pretreated 56 prevalences 56 SYNTAX 56 carotid stenosis 56 pharmacokinetic PK 56 subanalysis 56 fragility fractures 56 chronic HCV infection 56 generalizability 56 cilostazol 56 randomized controlled clinical 56 randomized controlled trials 56 epidemiologic studies 56 Multicenter 56 acute coronary syndromes ACS 56 neoadjuvant 56 lipid lowering therapy 56 candesartan 56 Fibrillex TM 55 composite endpoint 55 % CI #.#-#.# [003] 55 randomized controlled 55 Patient Registry 55 laboratory abnormalities 55 PRECISE 55 revascularization procedures 55 SWOG 55 multicenter study 55 nonoperative 55 superficial bladder cancer 55 forodesine 55 Phase III randomized 55 Pivotal Trial 55 thrombophilia 55 stable angina 55 randomized trials 55 eplerenone 55 Ischemic 55 multicenter randomized double 55 randomized clinical 55 Phase Ib II 55 androgen deprivation 55 SHPT 54 vaccinees 54 AREDS 54 multivariate analyzes 54 thromboembolic 54 Arch Intern Med 54 APTIVUS 54 T2DM 54 QTc prolongation 54 seroprevalence 54 phase IIa

Back to home page